Aerie Pharmaceuticals, Inc. Form D Notices of Exempt Offering of Securities
Notices filed with the SEC for securities sold without registration under Regulation D or Section 4(a)(5), newest first. Values are as filed.
- 2014-09-23: Federal exemption Rule 506(b); Types of securities offered Debt; OptionToAcquire; SecurityToBeAcquired; Date of first sale 2014-09-08; Total offering amount $125,000,000.
- 2013-08-29: Federal exemption Rule 506; Types of securities offered Debt; OptionToAcquire; SecurityToBeAcquired; Date of first sale 2012-12-07; Total offering amount $18,000,000.
- 2012-12-19: Federal exemption Rule 506; Types of securities offered Debt; OptionToAcquire; SecurityToBeAcquired; Date of first sale 2012-12-07; Total offering amount $15,000,000.
- 2010-09-01: Federal exemption Rule 506; Types of securities offered Debt; OptionToAcquire; Date of first sale 2010-08-27; Total offering amount $5,250,000.
| Filed | Federal exemption | Types of securities offered | Date of first sale | Total offering amount | Total amount sold | Total remaining to be sold | Investors who have already invested |
|---|---|---|---|---|---|---|---|
| 2014-09-23 | Rule 506(b) | Debt; OptionToAcquire; SecurityToBeAcquired | 2014-09-08 | $125,000,000 | $125,000,000 | $0 | 5 |
| 2013-08-29 D/A | Rule 506 | Debt; OptionToAcquire; SecurityToBeAcquired | 2012-12-07 | $18,000,000 | $15,000,000 | $3,000,000 | 5 |
| 2012-12-19 | Rule 506 | Debt; OptionToAcquire; SecurityToBeAcquired | 2012-12-07 | $15,000,000 | $3,000,000 | $12,000,000 | 5 |
| 2010-09-01 | Rule 506 | Debt; OptionToAcquire | 2010-08-27 | $5,250,000 | $5,250,000 | $0 | 3 |